Innovative Delivery Solutions by Liquid Nano Technology
LDS is a privately owned nano and biotechnology company focusing on the development of novel liquid nano-sized delivery vehicles.
LDS proprietary drug delivery systems enable solubiliztion of large loads of water-insoluble and poorly-permeable drug molecules as well as bio-macromolecules, enhancing the drug transport across human membrane.
LDS unique technology creates new indications for generic or innovative drugs, using safe-to-use components, which are all categorized as GRAS (Generally Recognized As Safe) and/or are listed within the FDA Inactive Ingredients Guide (FDA IIG).
LDS has broad intellectual property rights covering its drug delivery technologies.
LDS Delivery Platform Technology Can Be Adapted for Various Administration Routes Including Dermal, Trans-Dermal, Intravenous, Intramuscular, Oral and Ophthalmic Applications.
LDS mission is to enhance the permeation of water-insoluble and chemically unstable bioactives
LDS can replace generic drug formulations with significant disadvantages by new and improved formulations to be:
safer (chemically and physically), more bioactive, with less irritation and pain, with enhanced permeability and more.
LDS’ advanced drug delivery technologies increase the patient's compliance and quality of life by offering a drug with reduced side-effects and greater convenience.
HISTORY AND EXPERTISE
LDS was established in cooperation with Yissum, the technology transfer company of the Hebrew University. LDS is based on profound and vast research of Professor Nissim Garti on nano-size lipid-based systems. LDS improved significantly the nano-vehicle structure and the drugs bioavailability. Prof. Garti is an international expert and acknowledged specialist in the field of colloids science, disperssion technology and interfacial phenomena.
LDS Unique and Proprietary Nano-Sized Systems:
Enable high transmembrane permeation, resulting in enhanced bioavalability
Easy to prepare and cost effective to manufacture
LDS formulations are thermodynamiclly stable resulting in much longer shelf-life
Allow the combination of large soluble and small insoluble molecules to be jointly delivered
LDS structures are composed of safe-to-use, non-toxic compounds (FDA approved and GRAS listed)
LDS vehicles can be modified to extend drug release